[{"address1": "240 East Grand Avenue", "address2": "2nd Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 388 5600", "website": "https://www.oricpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Dr. Richard A. Heyman Ph.D.", "age": 67, "title": "Founder, Independent Chairman & Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 100000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob M. Chacko M.B.A., M.D.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1039037, "exercisedValue": 0, "unexercisedValue": 8489789}, {"maxAge": 1, "name": "Mr. Dominic G. Piscitelli CPA, M.B.A.", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 684155, "exercisedValue": 0, "unexercisedValue": 1460951}, {"maxAge": 1, "name": "Dr. Pratik S. Multani M.D., M.S.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 735587, "exercisedValue": 0, "unexercisedValue": 2520060}, {"maxAge": 1, "name": "Dr. Charles L. Sawyers B.A., M.D., Ph.D.", "age": 65, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott W. Lowe Ph.D.", "title": "Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin  Brodbeck Ph.D.", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lori Sickels Friedman Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian V. Kuhlen Esq., J.D., M.D.", "age": 51, "title": "General Counsel", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Iazzetti", "title": "VP & Head of People", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 11.48, "open": 11.51, "dayLow": 11.02, "dayHigh": 11.8, "regularMarketPreviousClose": 11.48, "regularMarketOpen": 11.51, "regularMarketDayLow": 11.02, "regularMarketDayHigh": 11.8, "payoutRatio": 0.0, "beta": 1.309, "forwardPE": -5.724138, "volume": 1395028, "regularMarketVolume": 1395028, "averageVolume": 1317489, "averageVolume10days": 1203110, "averageDailyVolume10Day": 1203110, "bid": 8.39, "ask": 14.2, "bidSize": 2, "askSize": 2, "marketCap": 1131663360, "fiftyTwoWeekLow": 3.895, "fiftyTwoWeekHigh": 14.93, "allTimeHigh": 40.81, "allTimeLow": 2.36, "fiftyDayAverage": 12.2945, "twoHundredDayAverage": 9.286375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 851918400, "profitMargins": 0.0, "floatShares": 63778291, "sharesOutstanding": 97389279, "sharesShort": 15494904, "sharesShortPriorMonth": 11242529, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1595, "heldPercentInsiders": 0.066939995, "heldPercentInstitutions": 1.07311, "shortRatio": 10.75, "shortPercentOfFloat": 0.1616, "impliedSharesOutstanding": 97389279, "bookValue": 4.183, "priceToBook": 2.7779105, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -135270000, "trailingEps": -1.71, "forwardEps": -2.03, "enterpriseToEbitda": -5.803, "52WeekChange": 0.17730498, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 11.62, "targetHighPrice": 25.0, "targetLowPrice": 15.0, "targetMeanPrice": 19.91667, "targetMedianPrice": 20.0, "recommendationMean": 1.21429, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 287140000, "totalCashPerShare": 2.948, "ebitda": -146819008, "totalDebt": 7395000, "quickRatio": 14.23, "currentRatio": 14.649, "debtToEquity": 1.817, "returnOnAssets": -0.25234, "returnOnEquity": -0.39731997, "freeCashflow": -70696376, "operatingCashflow": -116541000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ORIC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1587735000000, "postMarketChangePercent": 2.323584, "postMarketPrice": 11.89, "postMarketChange": 0.27000046, "regularMarketChange": 0.14, "regularMarketDayRange": "11.02 - 11.8", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1317489, "fiftyTwoWeekLowChange": 7.725, "fiftyTwoWeekLowChangePercent": 1.9833119, "fiftyTwoWeekRange": "3.895 - 14.93", "fiftyTwoWeekHighChange": -3.3100004, "fiftyTwoWeekHighChangePercent": -0.2217013, "fiftyTwoWeekChangePercent": 17.7305, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.71, "epsForward": -2.03, "epsCurrentYear": -1.6558, "shortName": "Oric Pharmaceuticals, Inc.", "longName": "ORIC Pharmaceuticals, Inc.", "priceEpsCurrentYear": -7.017756, "fiftyDayAverageChange": -0.67450047, "fiftyDayAverageChangePercent": -0.054861967, "twoHundredDayAverageChange": 2.3336248, "twoHundredDayAverageChangePercent": 0.25129557, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 1.21952, "regularMarketPrice": 11.62, "corporateActions": [], "postMarketTime": 1763767779, "regularMarketTime": 1763758801, "exchange": "NMS", "messageBoardId": "finmb_303713108", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "ORIC Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]